Gj. Molderings et al., MODULATION OF NORADRENALINE RELEASE FROM THE SYMPATHETIC-NERVES OF HUMAN RIGHT ATRIAL APPENDAGES BY PRESYNAPTIC EP3-RECEPTORS AND DP-RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 440-444
Strips of human right atrial appendages were preincubated with [H-3]no
radrenaline and then superfused with physiological salt solution conta
ining inhibitors of uptake, and uptake(2). Tritium overflow was evoked
by transmural electrical stimulation (standard frequency: 2 Hz). Pros
taglandin E-2 (PGE(2)) inhibited the electrically evoked tritium overf
low; at the highest concentration investigated, tritium overflow was r
educed by about 80% and the pIC(50%) value was 7.14. The effect of PGE
(2) was not affected by rauwolscine, which, by itself, increased the e
voked overflow. Naproxen failed to affect the evoked tritium overflow
and its inhibition by PGE(2). The inhibitory effect of PGE(2) on the e
lectrically evoked tritium overflow was mimicked by prostaglandin E-1,
the EP1/EP3-receptor agonist sulprostone and the EP2/EP3-receptor ago
nist misoprostol with the rank order of potency (pEC(50%)): sulproston
e (7.68) > misoprostol (7.10) > PGE(1) (6.39). In contrast, PGF(2 alph
a), the IP/EP1-receptor agonist iloprost and the stable thromboxane A(
2) analogue U46619 (9,11-dideoxy-11 alpha,9 alpha-epoxy-methanoprostag
landin F-2 alpha) did not change evoked tritium overflow PGD(2) caused
facilitation. These results suggest that the sympathetic nerve fibres
innervating human atrial appendages are endowed with presynaptic inhi
bitory EP3 and facilitatory DP-receptors. The EP3-receptors appear not
to be tonically activated and do not interact with the alpha(2)-autor
eceptors.